BXP, Inc.

Good day and thank you for standing by. Welcome to BXP's third quarter 2022 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. Please be advised that today's conference is being recorded. I'd now like to hand the conference over to your first speaker today, to Helen Han, Vice President of Investor Relations. Please go ahead.

Good morning, and welcome to BXP's third quarter 2022 earnings conference call. The press release and supplemental package were distributed last night and furnished on Form 8K. In the supplemental package, BXP has reconciled all non-GAAP financial measures to the most directly comparable GAAP measure in accordance with Reg G. If you did not receive a copy, these documents are available in the investor section of our website at investors.bxp.com. A webcast of this call will be available for 12 months. At this time, we would like to inform you that certain statements made during this conference call, which are not historical, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Although BXP believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Factors and risks that could cause actual results to differ materially from those expressed or implied by forward-looking statements were detailed in yesterday's press release and from time to time in BXP's filings with the SEC. BXP does not undertake a duty to update any forward-looking statements. I'd like to welcome Owen Thomas, Chairman and Chief Executive Officer, Doug Lindy, President, and Mike LaBelle, Chief Financial Officer. During the Q&A portion of our call, Ray Ritchie, Senior Executive Vice President, and our regional management team will be available to address any questions. We ask that those of you participating in the Q&A portion of the call to please limit yourself to one question. If you have an additional query or follow-up, please feel free to rejoin the queue. I would now like to turn the call over to Owen Thomas for his formal remarks.

Thank you, Helen, and good morning, everyone. Today, I will cover BXP's continued strong execution as demonstrated in our third quarter results. I'll provide a brief update to my remarks at our recent investor conference on the economy, return to office dynamics, and the premier workplace market. I'll discuss private equity capital market conditions for office real estate, BXP's capital allocation activities and provide a reminder from the investor conference of BXP's strategic shifts given current market conditions. Our SFO per share this quarter was well above both market consensus and the midpoint of our guidance. And we once again increased our forecast for full year 2022. We completed 1.4 million square feet of leasing just below our long-term average leasing activity for the third quarter. And year-to-date, we've leased 4.6 million square feet, which is meaningfully above our long-term leasing activity for the first three quarters of the year. This success is due to our team's strong execution, increasing return to the office behavior by workers, and the strong preference of our clients for premier workplaces, which are the hallmark of BXP's strategy and portfolio. Also in the quarter, BXP reinforced its ESG credentials by earning the highest five-star rating in the 2022 GRESB assessment, as well as its 11th consecutive green star recognition. We also commenced a partnership with the New York State Energy Research and Development Authority as part of the Empire Building Challenge, a public-private effort to support low-carbon retrofits and high-rise buildings in New York City to reduce emissions and combat climate change. As a company, we remain focused on climate action and are on track to achieve carbon-neutral operations in 2025. Now, I covered in detail at BXP's investor conference in September our views of economic conditions, client preferences, and in-person work behavior, and market statistics for premier workplaces. So in terms of what's new, inflation unfortunately remains resilient. The Fed remains committed to taming it through higher interest rates, and as a result, markets remain volatile. Workers continue to return to the office as our badge swipes grow each week, led by non-technology industry clients. Premier workplaces, as defined by CBRE, represent only 17% of the office inventory in the five CBDs where we operate. And this segment continues to outperform the broader office market. At the end of the third quarter, vacancy in these five CBDs was 9.1% for premier workplaces and 14.8% for the rest of the market. Net absorption in the third quarter was negative 200,000 square feet for premier workplaces and negative 1.7 million square feet for the rest of the market. Net absorption for the last seven quarters was negative 900,000 square feet for premier workplaces and negative 17.3 million square feet for the balance of the market, obviously a very significant difference. Given that 94% of BXP CBD space competes in the premier workplace market, we believe it's increasingly necessary to understand operating trends for the premier workplace segment of the market to assess and forecast our leasing performance. In terms of real estate capital markets, transaction volume for office assets slowed to $18 billion in the third quarter, down 11% from the second quarter and down 41% from the third quarter last year. We expect transaction volumes to decline further, particularly in the next few quarters. Debt financing is increasingly expensive and difficult to arrange. And many institutional buyers have withdrawn from the market due to real estate over-allocations caused by the denominator effect and or a view that more attractive entry points for new investments will be forthcoming in future quarters. There are, however, were several transactions of note in the third quarter. In the office sector, the most significant transaction was our sale of 601 Massachusetts Avenue in Washington, D.C. for $531 million to a non-U.S. property company. The 480,000 square foot building is 98% leased and sold for a 5.1% initial cap rate and $1,110 a square foot. In New York City, 1330 Avenue of the Americas sold for $320 million to a private investment firm. The 536,000 square foot building is 85% leased and sold for just under $600 a square foot and a 5.7% cap rate. In the lab sector, there were four significant transactions completed in Cambridge, the Seaport District of Boston, and South San Francisco for a total of over $1.6 billion. Pricing ranged from a 4.2 to a 5.5% cap rate and approximately $1,200 to $2,200 per square foot. BXP was active this quarter with capital allocation. We completed a significant transaction with Biogen involving two adjacent buildings, in our Kendall Center project. We acquired 125 Broadway, a 271,000 square foot lab building that Biogen has agreed to lease back for six years for $592 million, which is $2,185 a square foot. Immediately adjacent is 300 Binney Street, a 195,000 square foot office building owned by BXP and leased to Biogen for six remaining years. We terminated Biogen's lease, will convert the building to lab use, upsize to 240,000 square feet, and entered into a new lease with the Broad Institute for 15 years at significantly higher rents. The total cost to redevelop 300 Binney Street is $210 million, and the building will be delivered in the fourth quarter of 24. For both investments, the projected blended initial cash return is over 7%, including the acquisition cost of 125 Broadway and the redevelopment cost foregone Biogen rent and initial cost basis for 300 Binney Street. The projected blended gap yields are materially higher given the 3% annual rent escalations in both the Biogen and Broad Institute leases. We also continue to advance pre-development work for 290 Binney Street, a 570,000 square foot lab development that is 100% pre-leased to AstraZeneca, and our 121 Broadway residential tower, also both located in Kendall Center. Assuming all pre-development hurdles are achieved, we expect these projects will commence in early 2023. Strategically, we are making major steps forward in our life science ambitions by acquiring, developing, and redeveloping at attractive yields significant lab space at Kendall Center, one of the leading preferred locations for life science clients in the world. We also just announced an agreement to acquire a 27% interest in 205th Avenue, one of the top five premier workplaces in the Midtown South Submarket of New York City, located directly on Madison Square Park. The building comprises 870,000 square feet and is 93% leased to leading clients such as Tiffany, Gray Advertising, and Eataly. The acquisition price for our interest implies a building valuation of $1.05 billion, which equates to just over $1,200 a square foot, and a 5.3% initial cap rate. The building has a $600 million first mortgage that matures in 2028 and bears interest at a fixed rate of 4.34%, which is well below current market rates. BXP will assume management and leasing from the current developer who is monetizing their interest in the asset. We are entering into the existing partnership, and as a result, we'll grow our relationship with JP Morgan Global Alternatives, a leading real estate investment advisor. This investment was sourced off-market. Strategically, we are excited to grow our presence in Midtown South and add such a leading premier workplace to the BXP portfolio. We remain active with dispositions as well, given the recent announcement of our contract to sell the Avant, a 15-story, 359-unit luxury multifamily building in Reston, which we built in 2013. The sale price is $141 million, or $393,000 per unit, which represents a 4.3% cap rate on current NOI. We also sold a 10-acre land parcel in Loudoun County Virginia for $27 million to a data center developer. Both sales, along with 601 Mass Ave, will be like-kind exchanged with the Madison Center acquisition. Our previously described strategy to reallocate capital from the Washington, D.C. region to Seattle is now complete, having sold assets totaling approximately $700 million to fund the $730 million acquisition. We do not anticipate any further sales this year and our total dispositions in 2022 is projected to be $864 million. Our development pipeline remains robust as we added this quarter a 104,000 square foot building at 140 Kendrick Street in Needham, Mass., that we are redeveloping to net zero carbon performance for Wellington Management. and the 118,000 square foot 760 Boylston Street Retail Building at the Prudential Center in Boston that is also fully leased. Our current development pipeline of 13 office, lab, residential, and retail projects, as well as View Boston, the observation deck at the Prudential Center, aggregates 4.4 million square feet and $2.7 billion of investment that we project based on delivery date and lease-up assumptions to add nearly $200 million to our NOI over the next five years at a 7.4% weighted average cash yield on cost when stabilized. The commercial component of our development pipeline is 52% pre-leased. These figures exclude the positive contribution of 300 Binney Street, which will be added to the development pipeline in the first quarter of next year. In closing, I'd like to reiterate the strategic shifts BXP is executing as a result of the pandemic and current economic slowdown. We will continue to embrace our leadership position in the premier workplace industry and leverage our strengths in portfolio quality, client relationships, development skills, market penetration, and sustainability to profitably build market share. We will pursue attractive asset class adjacencies where BXP has a track record of success which today are life sciences, as evidenced most recently by the transaction with Biogen, and multifamily development. We will continue to raise the quality bar for our portfolio and actively recycle capital by selling assets as we did in 2022, subject to market conditions. And lastly, given rising interest rates and financial market turbulence, we will prioritize risk management by actively managing liquidity, investing more extensively with joint venture partners to manage our debt levels, and being highly selective in new investment commitments. Though near-term challenges in the capital markets confront BXP in our industry, we are confident our platform, strategy, and team will build market share and continue to create value over the long term. Let me turn the discussion over to Doug.

Thanks, Owen. Good morning, everybody. So I'm going to pivot the discussion this morning to our 2023 earnings guidance. We expected and saw a number of notes last night, so obviously this is of critical importance to everybody. And I think we outlined a bunch of the critical variables in the press release, and Mike is going to provide some commentary on the most significant components in his remarks. I am going to focus my remarks on our in-service operating portfolio, which is really driving our same property expectations. But I'm going to start with what happened in the third quarter, because I think the trends that I'm describing are going to be relatively relevant to our forward assumptions as we think about 2023. So the third quarter was another really good leasing quarter for BXP. It's now the sixth straight quarter of strong overall leasing activity in the portfolio. Just to remind everybody, beginning in the second quarter of 21, we signed $1.2 million, $1.4 million, $1.8 million, $1.2 million, $1.9 million, and this quarter $1.4 million square feet of leases. So that's about $6.3 million over the last 12 months. Obviously, it's a deceleration between the third quarter from the second quarter. We have successfully executed leases with clients in the midst of the Delta variant, the Omicron variant, remote work fits and starts, significant labor market headwinds, and now what is surely a pullback in business activity. The Boston CBD led our activity this quarter with about 260,000 square feet of leases, including some renewals, expansions, and the addition of new clients into the portfolio. The mark-to-market on the previously leased space, and again, I'm giving you data on the leases that were signed this quarter, not leases that are in our supplemental, which may have happened two or three or four years ago, but the mark-to-market on the spaces this quarter was 15% positive. The lease at 300 Binney Street, dominated our Cambridge activity this quarter. And because we are moving from a 2011 office lease to a 2024 lab lease, the markup is over 250%. So it's a very, very significant increase. The suburban 128 workspace market remains slow with all of our leasing under 10,000 square feet, other than a 55,000 square foot renewal that we did. There, the markup was about 3%. This was also an unusually busy quarter for our retail space, including the 118,000 square feet at 760 Boylston. We completed 181,000 square feet of retail leasing in the Boston region this quarter. We didn't complete any new life science leasing in the Waltham Lexington portfolio, where we have our buildings under construction. The life science market has seen a significant slowdown. We have available space at both of these developments that we are aggressively marketing. As we discussed at our investor day, there are a number of other suburban buildings that we have been vacating in order to be in a position to redevelop them as lab buildings. These buildings are not yet under development, so they reduced the portfolio occupancy that we're showing. At the present time, we have not made any commitments to begin any additional developments of these assets, but we are vacating these buildings intentionally. In New York City, We completed 250,000 square feet of leasing. Much like Boston, in Manhattan, we saw a number of renewals, expansions, and new clients join the portfolio. The mark to market on the second generation space that was recently occupied was down about 4%. New activity in New York City was off in September, but we have seen a meaningful pickup during the month of October. As a case in point, on September 30th, we had no active discussions on our 120,000 square foot block of space at 599 Lexington Avenue. Today we have three active proposals covering over 70,000 square feet of that space. We completed another lease at dock 72 this quarter, but we work relinquished space on October 1st that will mute the contribution to occupancy as you look at it next quarter. In Princeton, we completed six transactions with professional and financial firms totaling 40,000 square feet with an increase of rent of three and a half percent. In DC, We completed four leases for about 100,000 square feet. This is in CBD, including one lease renewal with a markdown of about 12%. Now, remember, in D.C., the lease structure has 2% to 3% annual increases for leases that are generally 10 to 15 years. So in virtually every renewal, the last year of a 10 to 15-year lease with a 2.5% to 3% increase is less than the starting rent of the new lease. So that's typically what we see all the time there. Small financial and professional service firms made up the activity in Northern Virginia, where we saw about 50,000 square feet of activity, and the largest lease was only 15,000 square feet. The markdown was about 3.5% on that portfolio. We continue to make progress at 2100 Penn, where we have 90,000 square feet of leases under negotiation that will bring that asset to 80% lease. Finally, in San Francisco, the story is the same as the other markets, though the lack of technology demand is more impactful on overall market sentiments. We completed eight CBD leases, all under 11,000 square feet, with professional services and financial clients. The markup was flat, with an average starting rent of about $100 a square foot. Down in the valley, we did 92,000 square feet with three renewals and added one client. The 60 basis points of occupancy lost this quarter was in line with our comments and expectations from last quarter. These three assets were removed from the portfolio. 601 MAPF, obviously, which was sold and 100% leased. 140 Kendrick Street, Building A, which is 100% leased and is in redevelopment, and our large box at the Prudential Center, 760 Boylston, which is 100% leased and in redevelopment. Shearson's 350,000 square foot 20-year lease renewal at 599 Lex commenced this quarter, and they relinquished 120,000 square feet, the block I was describing. Biogen moved out of the first portion of 300 Bitty Street, which will eventually grow by 40,000 square feet when it's converted to lab and it's fully released. The partial termination is reflected in our statistics, not the new lease. Biogen will vacate the rest of this 195,000 square foot building in the first quarter of 2023. So we're going to lose occupancy on that as we redevelop it for the long-term addition of a lab building. At Santa Monica Business Park, we had a post-movie operation that completed their use of space this quarter, and they moved out. Our second-generation leasing decisions for the quarter, if you look at our FAD in particular, include the Sherman transaction at 599 Lex. They converted a bunch of their free rent to TI, and the entire cost for that 20-year, 350,000 square foot lease is in the FAD this quarter, which is why the FAD looks unusual. The global central bank tightening has resulted in softened demand in all the markets. While tours continue and leases under construction move forward, under negotiation move forward, there is less urgency from clients to make new commitments. We have conversations with potential clients during space tours who acknowledge that economic uncertainty is impacting space decisions. As we consider our expectations for leasing completions in 23, we're factoring the impact of a materially slower economy softer business performance, and reduced demand for space. We expect the bulk of our leasing will continue to come from small and medium-sized professional and financial services firms. So as we think about 23, let's start with what we know. We have signed leases on more than 886,000 square feet of in-service vacant space that are not in our occupancy figures. Approximately 700,000 will commence in 2023, the remainder in 24. At the end of the third quarter, we had active leases under negotiation in the in-service portfolio of about 800,000 square feet. 270 of that would cover currently vacant space that will go into service in 2023. The rest is on our near-term expiration. In sum, we have visibility on about a million square feet of currently vacant space and about 500,000 square feet of expiring leases. To the remainder of 22 and 23, totals about 3 million square feet of expirations. This would mean we need to lease about 1.8 million square feet with 2023 commencements to remain flat. We typically lease more than a million square feet on a quarterly basis. Obviously, I describe what happened over the last six quarters where the lowest was about 1.2 million. The issue is the timing of lease commitments on vacant space. That's the big wild card. We just don't know if we sign the lease, whether the space is going to be in a shell condition or an as-is condition, and whether that lease is going to commence in 2023 or 2024. What we said last quarter remains true. We will see a slight decline over the next few quarters as we wait for all signed leases to commence, but in spite of our less robust leasing expectations, we still anticipate an improvement as we move into 2024. Tour activity continues to be strongest in the Boston CBD and New York City markets, where the concentration of technology users is least pronounced. and the weighting of market occupancy leads more heavily towards financial and professional services firms. Consistent with my earlier remarks on the third quarter, small and medium-sized financial and professional services firms continue to be the most active portion of our portfolio as those tenants' clients look for premier workspaces. These users are also active, though, to a lesser extent in D.C., San Francisco, and Reston. We have all seen the announcements regarding hiring freezes, job reductions through attrition, and explicit job cuts that are occurring on a consistent basis from many of the large technology employers. In some cases, these announcements coincide with decisions to put space on the sublet market. It's hard to envision much technology related demand growth in 2023. Owen described the stark divergence between premier workplaces and everything else. When clients do make space decisions, we expect them to gravitate to premier workplaces that we have at BFB. I want to make a few more points about the same property portfolio before I hand the speaker over to Mike. The elimination of income from 300 Binney Street as we redevelop this fully leased building into a lab building is about $10 million in 2023 relative to 22. The reduction in income from the Boston suburban assets as well as a building in Carnegie Center and Shady Grove properties in Maryland that we are now enabling for life science constitutes a reduction of about $10 million in 2023 from 2022. This positions us to add life science portfolio properties over time. We expect our parking income to be about 90% of the 2019 level and up about 6% from 2022 estimates. Our retail portfolio has come back in Boston, New York City, and DC, where we have a significant number of new spaces under construction with 23 openings. The West Coast continues to be laggard. We expect little change in contribution from retail in San Francisco in 23. The daily traffic in our West Coast portfolio continues to be dramatically lower than the East Coast. We continue to provide extensive subsidies to many of our retail tenants in San Francisco. In spite of the challenges with the new lease at 760 Boylston, we expect the overall contribution from retail to return to 2019 levels by the middle of 24 when the lease at 760 commences. In summary, we have reduced our total leasing expectations in 23 due to the issues stemming from the aggressive battle against inflation and the ensuing slowdown in the economy. We still expect occupancy improvement in 23, though at a reduced rate. Our flat same store guidance is based on these variables. Mike, take it away.

Great. Thanks, Doug. Good morning. So today I plan to cover the details of our third quarter performance and also the increase to our 2022 full year guidance. And I will spend most of my time describing the details of our 2023 initial earnings guidance. The third quarter results were strong. We reported third quarter funds from operation of $1.91 per share. that was 4 cents per share higher than the midpoint of our guidance. The improvement came from better than anticipated portfolio performance. Higher revenues contributed 3 cents per share to our results from earlier than projected revenue commencement on space that we delivered to clients ahead of schedule. And we also exceeded our budget for parking revenues, particularly in Boston, where return to office continues to grow. Lower operating expenses also contributed 3 cents per share This was primarily from lower-than-projected repair and maintenance costs, most of which will be deferred into the fourth quarter. These positives were partially offset by the termination of our lease with Biogen at 300 Benny Street in Cambridge. The lost revenue resulted in a $0.02 per share reduction in revenue versus our budget that assumed full rent and occupancy for the quarter. While not part of FFO, our net income included gains on asset sales of $262 million, or $1.50 per share, primarily from the sale of 601 Mass Avenue in Washington, DC. Our asset sales this quarter raised $540 million in net cash proceeds. On the new investment side, our acquisition of 125 Broadway, a fully leased lab facility in Cambridge, utilized $592 million of cash. For the rest of 2022, we have increased our guidance for full year funds from operation to $7.51 to $7.53 per share. That's an increase of two cents per share at the midpoint from our prior guidance. The increase is projected to come from higher revenue from the portfolio and our 125 Broadway acquisition, partially offset by the deferral of third quarter operating expenses into the fourth quarter and higher interest expense from both higher floating interest rates and incremental debt from funding our new investments. The new midpoint of our 2022 guidance represents strong growth in FFO of $0.96 per share, or 15% over 2021. At the midpoint of our guidance, our growth is comprised of 3.75% year-over-year improvement in our same property NOI. That adds $0.35 per share. $0.63 per share of external NOI growth from acquisitions and developments coming online. and $0.16 per share of lower interest expense from locking in low rates in our financing activities last year. These positives are partially offset by the loss of $0.15 per share from asset sales and $0.03 per share of other items, primarily higher G&A expense. Overall, we expect 2022 to be one of the strongest years for earnings growth in the company's history. Now I'd like to turn to our initial guidance for 2023. The most significant impact by far to next year's guidance is the dramatic increase in interest rates in 2022, which is expected to continue into 2023. Stubborn inflation is leading to even more aggressive actions by the Fed that are having a meaningful impact on borrowing costs. Our assumptions include the Fed increasing short-term rates to 4.75%, which drives an increase in the borrowing costs under our line of credit and term loan facilities into the high 5% range. We currently have $1.9 billion of floating rate debt that comprises just 14% of our share of total debt, so we still have the vast majority of our debt being fixed. Our floating rate debt includes outstanding amounts under our line of credit, our $730 million term loan, and $800 million representing our share of floating rate debt in our unconsolidated joint venture portfolio. In addition, we anticipate that our floating rate debt will likely increase in 2023 as we use our line of credit to fund a portion of our development spend. A change in our assumption for short-term rates of 50 basis points either way impacts our projected earnings by $0.06 per share. Owen described the new acquisitions and developments that we announced during the quarter. This use of capital results in a projected $50 million of incremental interest expense. So overall, our assumptions for interest expense in 2023 are an increase of approximately $122 million at the midpoint of our range. This amount includes our consolidated interest expense and our share of unconsolidated joint venture interest expense. At the midpoint, this is an increase of 69 cents per share of interest expense from 2022. Doug provided a substantial amount of detail on the changes in our same property portfolio. Our leasing assumptions reflect the uncertainty in the broader economic environment that has resulted in elongating the lease up of some of our vacant and expiring space. In addition, as Doug said, we have several projects that we are targeted for future life science conversions where we are intentionally creating vacancy. We still expect to have a productive leasing year, and we have a large backlog of signed leases and leases in negotiation that will go into occupancy over the next 12 months. Overall, we expect our occupancy to be relatively stable year over year. We project our 2023 same property NOI growth to be flat from 2022, and we expect that we will have positive same property cash NOI growth, and our guidance assumes growth of 1% to 2.5%. We anticipate that we will see strong external growth in 2022 from the delivery of developments and the impact from a full year of our 2022 acquisition program. Next year, we will fully deliver our 880 Winter Street Life Science facility that is 97% leased, our carbon net zero redevelopment of our building at 140 Kendrick Street that is 100% leased, and View Boston, our immersive observation experience at the Prudential Center. We will also see a full year from our 2022 deliveries, including our Google building in Cambridge, 2100 Pennsylvania Avenue, and Reston Next. In aggregate, we project our developments will add between $55 and $65 million in incremental NOI in 2023. This year, we acquired Madison Center in Seattle and 125 Broadway in Cambridge, and we just announced the acquisition of an interest in 205th Avenue in New York City that Owen described. In 2023, we project these acquisitions to provide an incremental $45 to $50 million to our NOI. We were also an active seller in 2022, And as Owen described, we currently have the Yvonne residential building under contract. In total, we project sales for the year of $864 million, which we expect will reduce our portfolio NOI by $28 to $30 million in 2023. The other changes that impact our 2023 guidance are a modest expected decline in fee income due to a $7 million assignment fee we generated in 2022 that we do not expect to recur. and we project that our G&A will increase by approximately 5% next year. So to summarize, we expect our 2023 FFO to be lower than 2022 by approximately 4%, or 30 cents per share, primarily due to higher interest expense. At the midpoints of our guidance, we expect growth from our acquisitions and developments of 62 cents per share, offset by higher interest expense of 69 cents, a reduction in NOI from asset sales of 16 cents, lower fee income of 3 cents, and higher G&A expense of 4 cents. While we are never happy forecasting a reduction in FFO, 4% is relatively modest and entirely due to a steep increase in interest rates. Our portfolio NOI continues to grow, and we have a significant pipeline of accretive developments delivering over the next few years. That completes our formal remarks. Operator, can you open the lines for questions?

Thank you, sir. As a reminder, to ask a question, you will need to press star 11 on your telephone. We ask that you keep your questions to no more than one, but please feel free to go back into the queue, and if time permits, we'll be more than happy to take your follow-up questions at that time. Please stand by while we compile the Q&A roster. I show our first question comes from the line of John Kim from BMO Capital Markets. Please go ahead.

Good morning. I was wondering if you can comment on your occupancy guidance for 2023. I realize, Doug, you mentioned some of this is timing related and you're expecting a slower economy next year. But can you also comment on if you've already seen leasing activity slow down this quarter? And also, if you're factoring in lease termination increasing in 2023. Sure. So, I'll back up.

That was a three-parter, but I'm going to give you credit for it all being at least consistent with each other. So lease terminations are not included in our occupancy. Things are definitely feeling slower in the fourth quarter than they did in the third quarter of 2022. And again, we believe that our occupancy will be higher at the end of 2023 than it will be at the end of 2022 because we have visibility on a significant amount of leases that

have already been signed and we are we're covering a significant amount of our existing portfolio vacancy today thank you and i sure our next question comes from the line of steve sakwar from evercore isi please go ahead uh thanks good morning uh owen or doug could you just comment on how you guys are adjusting your return hurdles on development and maybe just speak to the acquisition of 205th, you know, in this environment, you know, I guess why pursue acquisitions?

Steve, it's Owen.

Good morning. Clearly, our cost capital is going up as indicated in what we've reported. And I do think our hurdle for new acquisitions is going up from a quality standpoint and also from a return standpoint. You know, I referenced the The 125 Broadway and 300 Binney Street, you know, one is an acquisition and one is a redevelopment. And the blended yield on that when fully delivered is over 7%. You know, buildings in that location, certainly lab buildings in that location, have been trading in the four, maybe even the low four. So I think there's, you know, significant margin in that yield versus where we made the investment. And then as it relates to 205th, a couple things I would mention. One, I think it's a very unique property. It is clearly a premier workplace. I think transactions like that don't come around very often. Second, I think the cap rate is understated because it has below market debt on the property for the next six years. And then third, we're purchasing a minority interest, a stake, so it is not a full acquisition. The building requires less capital. But we are raising our hurdles for making new investments, and our pipeline is less right now for new investments as a result. I would say the largest thing we're working on, I mentioned in my remarks, which is the 290 Binney Street development and the 121 Broadway residential.

Thank you.

And I show our next question comes from the line of Derek Johnson from Deutsche Bank. Please go ahead.

Hi, good morning. Thank you. In your discussion with business leaders, do they view the likely recession as a tipping point for possible greater office utilization? And I guess thus, you know, the balance of power, you know, shifting, favoring employers versus employees, especially the mid-level employees. And, you know, has this factored into discussions with business leaders or perhaps they're thinking on future demand for space? Thank you.

I think the answer to your question is a little bit industry specific. You know, I certainly think amongst the financial service clients that we have, I think the slowdown in business conditions has, I think, put some more urgency on in-person work, and we're clearly seeing that. in the traffic, particularly in Boston and New York. I also, you know, I think, I'm not sure it's that big an impact yet on the technology sector, where the return to in-person work has been certainly lagging the other industries. And I do think there's an offset a bit as well in terms of what Doug described of, you know, a recession delaying leasing decisions by businesses because they're, you know, significant capital Events and, you know, in this kind of environment, businesses try to create optionality on doing those kinds of things. But yes, I do think slower business conditions are leading to more in person work behavior.

So, and Derek, I would just add the following, which I think is actually going to be helpful, but it's not going to be helpful in the short term in terms of improving things, which is that. As these businesses, I'd say, get more aggressive, I'll use the word, at asking their employees or associates to come back to work, I don't think it's going to lead to them taking more space. I think it's going to lead to a better urban platform environment whereby there are going to be more people in our cities on a day-to-day basis, which I think will be helpful over time at convincing businesses Both the workers and the employers that these cities really can potentially get back to where they were relative to the street platforms and be very vibrant local communities right now. One of the problems is there's sort of this vicious circle going on where, because there aren't as many people going to work every day, the cities feel different and the other sort of issues associated. with the urban nature of the challenges associated with crime, homelessness, et cetera, become more visible. And there's a sort of cycle that I think will be helpful as things go in the other direction.

Thank you. And I show our next question comes from the line of Nick Ulico from Scotiabank. Please go ahead.

Thanks. Good morning, everyone. Just in terms of J.V., you know, potential. You did talk about that at the Investor Day, you know, how you're thinking about maybe, you know, sales of existing assets or, you know, funding future development with joint venture partners. And then also, you know, in terms of the commentary you gave, Owen, on, you know, cap rates for the New York City assets, I guess in both of those cases, you know, the asset you purchased and then the sale of 30 1330 Avenue in the Americas, you know, they both had in-place debt, as you mentioned, that is below market today. And so I guess what we're all trying to figure out is, you know, what does this mean for cap rates going forward if, you know, instead you have to put new debt on buildings, which our understanding is that if you can even get it for the best buildings, you your cost of that debt is going to be over 6% today. So does that mean cap rates then would have to be over 6% by some fashion in order for underwriting to kind of work in this new world we're in? Yeah.

Okay. I think that was a three-part question, but I won't stick Helen on you. So first of all, JVs, We absolutely want to continue to do joint ventures, and we absolutely want to continue to sell assets. But it's going to be subject to market conditions. As I mentioned, there are many institutional investors who are more cautious on the market, somewhat withdrawn from the market for the reasons I mentioned in my remarks, denominator effect or a view that perhaps the market will get more interesting from a pricing perspective in the future. But again, subject to market conditions, that's absolutely what we want to do. go into your comparison of 205th to 1330 Avenue of the Americas. Humbly, I would say I think 205th is a higher quality asset and warrants a lower cap rate. I do think the below market debt does have some impact on how to think about pricing for the asset, because that's clearly an asset to have such a below market debt on the building. And to your point, with debt cost rising, I absolutely believe that there is some increase in cap rates. I think it has probably less in the office sector because I think office buildings have been trading at higher cap rates than some of the other real estate sectors. But I do think it has had some increase on where market cap rates are.

Thank you. And I show our next question comes from the line of Blaine Heck from Wells Fargo. Please go ahead.

Great, thanks. Good morning. So the tone on the call and in the press release sounds just a lot less optimistic than at your investor day. Owen and Doug, you guys did touch on this a bit in the prepared remarks, but can you just expand on the main kind of factors driving that change in tone, especially in such a short period of time?

So I guess let me just sort of back up. So our investor day was not about 2023 earnings guidance. Our investor day was about Here is Boston Properties' portfolio regarding its human capital and its assets and what we are trying to do from a strategic perspective in the context of where the market is today. And I don't think at any time did we talk about what we thought was going to happen in 2023. So I don't think anything that we said at that conference should be construed as different than what we're saying today. Regarding our outlook for actual leasing activity in 2023, I would tell you that we feel modestly less rosy about that because the Fed has been more aggressive than I think people expected when we had our conference in September 2022 relative to rate hikes. And the inflation has been more challenging to get under control. And all of that has effectively, you know, transferred itself into a higher interest rate expectation. Mike's using the dot plot, you know, we're using a four and three quarters percent average interest rate for our underlying index in 2022, right? So, and all of that sort of, from my perspective, manifests itself in less robust leasing activity in 2023, because I think the economy is going to be less strong and there are going to be less decisions that are made by companies relative to decisions on their space, be it staying in place and just upgrading to a premier workspace like our buildings or incremental growth. And so I guess that's, from my perspective, sort of the subtle change between what we were describing and, you know, in September and what we're talking about this morning.

Thank you. And I show our next question comes from the line of Camille Bonnell from Bank of America. Please go ahead.

Good morning. Given you have only entered an agreement to sell the residential component of the Yavon, can you please confirm if this asset disposal is reflected in the 2023 guidance you provided? And at your investor day, you mentioned we could see similar levels of sales as we have in 2022. Can you please provide an update on how you're thinking about dispositions in 2023? Has anything changed here?

So the answer to your question is yes, the Avant sale is reflected in the 23 guidance. And as it relates to sales, Mike and I both mentioned a figure of $864 million for 22, which assumes the Avant is sold. It's only under contract right now. And then we will continue, and I mentioned one of the strategic priorities for BXP is to continue to recycle capital and upgrade our portfolio into 2023. So our goal is to sell more assets. Since we don't know what those are, those are not reflected in the 23 guidance. And it's going to be subject to market conditions. You know, we have specific assets that we are looking at to sell, but it's, again, we are going to execute on those sales subject to receiving attractive pricing.

Thank you. And I show our next question comes from the line of Michael Griffin from Citi. Please go ahead.

Thanks. It's Nick Joseph here with Michael. Appreciate the color on the impact of rising rates on the business and guidance. But just going back to the financing market for office assets today broadly, what are you seeing the differences in terms of lender appetite, LTVs, rates, terms on Premier versus other assets?

This is Mike. I mean, I think that lenders are overall, you know, significantly more cautious about putting capital out for all the reasons that we've talked about. And credit spreads are clearly wider in all of the markets that we deal with. So, I mean, credit spreads in the bond markets are wider. Credit spreads in the mortgage markets are wider. I mean, I can't say they're at all time wide. but they're significantly wider of where I would say a normal environment is. You know, I think that CMBS is underwriting cash flow, and if there's rollover, they're very conservative about the rollover, and they're requiring reserves in order to mitigate the risk of rollover, and those reserves drive down proceeds levels that are available in the CMBS market for real estate assets. So I think that can drive down some of the leverage that you can get and could impact the refinancing of certain assets that might need to be recapitalized in order to refinance. If you have a high-quality property that has a long lease term, you can clearly get it financed. People will finance office buildings, other real estate with those types of lease terms. There's just going to be higher cost of capital. So with a treasury that is between four and four and a quarter and a credit spread that's probably between 250 and 300, You're talking about high sixes, the type of rate that you can get. But that financing is available today. And then the banks are also providing mortgage loans and term loans and things like this to the market to add liquidity as well. And you've seen a number of REITs, including ourselves, kind of use term loan financing to help fund new acquisitions and new investment. And that market is still available to us.

Thank you.

And I share our next question comes from the line of Alexander Goldfarb from Piper Sandler. Please go ahead.

Hey, uh, good morning. Uh, so a question, uh, is on Seattle. Uh, oh, and you guys, you obviously entered, uh, you know, the past, uh, and curious with what we're hearing about Amazon and potentially pulling back from Bellevue. Microsoft potentially reverting back to Redmond out of Bellevue. As you guys look at your Seattle exposure, you've expanded it. Is everything that's going on in Bellevue and the potential disruption that could occur, was all of that part of your original underwriting or has the broader Seattle Bellevue market changed since you initially entered the market and since you did the latest Madison acquisition?

So Alex, good morning. No, the Amazon moves in Bellevue were not part of our initial underwriting because it was not known. We remain confident in Seattle for the long term. We think we have two. We have one very high quality asset and one asset that we're going to make very high quality that we've already performed some leasing in. We have confidence in those assets. But as Doug described in his remarks, you know, the technology industry is a retrenching to some degree. You know, there have been layoffs announced. There have been space moves announced that you described. And, you know, we don't see this as a big provider of growth in the near term. But I think over the long term, these companies, you know, have technologies that will grow and they will be successful. But it's going to take a while to work through the environment that we're currently dealing with.

Thank you. And I show our next question comes from the line of Michael Goldsmith from UBS. Please go ahead.

Good morning. Thanks a lot for taking my question. FFO for share expectations for 2023 is down 4% from what you're anticipating for 2022. And this is primarily driven by pressure from interest expense as well as some other puts and takes. I'm not asking for guidance, but I guess like what needs to happen in order for BXP to return to earnings growth in the coming years? Can you get there with just the maturity of the developments or will it require a combination of more favorable interest rates and stronger fundamental demand? I'm just trying to get at the cadence of what needs to happen in order to get the company back on this path to earnings growth.

You know, I'll start and the others can, you know, lob in as well. Look, I think that we have a development pipeline that delivers revenue cash flow through 2025 as it goes into service. And that is going to continue to be a tailwind for us and provide growth for us as we deliver that pipeline and hopefully increase that pipeline with some opportunities that we have that we're working on. On the debt side and for interest rates, I mean, 2022 has been an extreme year of interest rate increases. And I think that our expectation is that they've got a little ways further to go up, but it's not going to continue to go up at this pace for the next two, three, four years, that there's going to be a point that is reached where the Fed has done its job and you start to see inflation turn where they're going to slow down the increases in the Fed rate, which will affect SOFR, and that will start to moderate and, you know, potentially turn the other way if the economy weakens like we have been talking about. So that's not in our expectation for 2023 because we assume the SOFA rate is going to go up and then it's going to stay flat. And we assume the small amount of refinancing that we need to do, which is very small because we don't have very much in the way of mortgages coming due, that we will have to refinance those at high permanent rates. So we have a $500 million bond coming due, for example, in, you know, the third quarter of 2023. And we can borrow in the bond market today for 10 years in the high sixes. So that's what we're assuming. So that has an impact on our interest expense guidance. If interest rates start to moderate and the 10-year comes down a little bit or slows its increase and credit spreads, which right now are as wide as they've been in a really long time, start to moderate because people kind of see the end of the rate hikes and see what the pain is going to be felt in the economy, we could see credit spreads come in. 50, 100, 125 basis points could help. Now, I don't know when these things are going to happen, but I do believe that, you know, we won't see the same increase in rates from 23 to 24 during 2020. that we saw in 2022. Yeah.

I would just add to Mike's remarks. First of all, on the development deliveries, as I mentioned, that's 200 million of NOI over the next five years. And that number excludes contributions from 300 Binney Street, which are material, which comes in the next couple years. So that's the quantification of that. Mike talked a little bit about the interest rate opportunity. And then the last piece is portfolio occupancy. Again, Doug went through a lot of math on how to think about that and the timing for it. But we're going through a business cycle. I said this at the investor conference. It's called a cycle for a reason. It doesn't last forever. And this will turn at some point. And when you looked at BXP before the pandemic, we were at 93%. So, again, we're not giving any forecast of what the timing for that is, but that's clearly a growth opportunity for the company just to increase the occupancy of our portfolios.

Thank you. And I show our next question comes from the line of Vikram Malhotra from Mizuho Group. Please go ahead.

Thanks so much. I just wanted to go back to sort of the occupancy trajectory and comments. Maybe just if you can unpack it a bit more for us, because I came away from the investor day definitely thinking there's upside to occupancy, even if you trend sort of lower on the leasing front. And you kind of gave some numbers at multiple presentations. So maybe you can just unpack this a little bit more by maybe the risk to market, where there are more risks, where there are upside. How do we think about just timing-wise or trajectory? And just, again, what's changed in the last month? It's a bit unclear just based on what you talked about a month ago.

So, Vikram, the only thing that's changed, I'll just repeat what I said before, is that I think we've moderated the amount of leasing that we will do in 2023 that has a 2023 lease commencement associated with it. And I'll sort of give you effectively how the sausage is made color on that, which is When we have space that is currently built out, and that space is re-let, we would start recognizing revenue when the lease commences. When we have a piece of space that we make a decision to go and demolish, okay, so we basically remove all the existing improvements, and those improvements are now, you know, referred to as sort of a white box condition, and we then do that lease, we have to wait until that tenant has completed their build out of the space. even if we're contributing the capital, until we can recognize revenue. So we have a bunch of spaces that we are building as a sort of white box right now because we think it will give us a leg up in terms of leasing that space that will, while it may actually improve the timing of actual cash revenue, may not help us relative to our, quote-unquote, revenue from an occupancy perspective in 2023. So that's really the only thing that has changed. With regards to the overall sort of going around the country perspective, as I think I said, our views and the pulse that we have on overall leasing activity is much stronger in our Boston and our New York City CBDs relative to tour activity and likelihood of transactions occurring than it is on the West Coast in San Francisco and Los Angeles and Seattle. And that's because the majority of the traffic that we're seeing are from professional services and financial services-oriented companies who are concentrated in those marketplaces in Boston and in New York City to a wider degree than they are in the West Coast markets, which are more concentrated with technology-oriented companies. And as I tried to describe, many of those transactions are the smaller transactions right there, a floor or less. And so we're doing a lot more of those than we are a three or four or five floor lease with a client who's in the technology business. And so I'd say that's sort of what's driving our near term views on our occupancy in 2023. But again, When we were, you know, when we sat up there and made our presentations, we were trying to describe to all the analysts in the room and all the investors in the room and on the phone how we were looking at Boston Properties from a long-term perspective. And I just, you know, I do want to make the point that we are in a long-term business relative to the decisions that we're making. So let's just, you know, Owen described 601 Mass Avenue and said, oh, by the way, we sold the building at a 5.1 cap rate. We acquired the land for 601 Mass Ave in 2008. We started a building in 2011. We completed the building in 2013, and we sold the building in 2022. And starting in 2008 to 2022, the unlevered IRR on that investment was 9.65%. So this is a business of long-term decisions and long-term investments. And so while we are focused dogmatically on providing you with guidance and our expectations quarter by quarter by quarter, because we're a public company and that's what we are required and want to do, when we're making our real estate decisions, we're making decisions based upon long-term investment perspectives. And so at times, that means that we might not be able to satisfy an immediate quarterly opportunity to do something because in the long term, we're better off doing something that may be short-term dilutive. So that's the way we approach our work and our business from an operating perspective and from an investment perspective.

Thank you. And I see our next question comes from the line of David Rogers from Baird. Please go ahead.

Yeah, good morning, everybody. Doug wanted to follow up just on the leasing numbers that you quoted earlier. I think it was at the investor day you had signed 1.8 million square feet. That probably grew to 2.2 by the end of the quarter, if it's just simple math. And then today you talked about about 860,000, I think, of vacancy leasing. So I guess I wanted to dovetail the combination of those. Is the rest all renewal leasing? Can you talk about how that reduces your expirations maybe next year and the spreads on that, if that's true? And just kind of verify my numbers if I'm thinking about it right.

So all the numbers I used at the investor conference were as of June 30th of 2022, so everything was sort of a quarter delayed. And lots of things happened during the third quarter that are now reflected in the numbers, both in terms of leases that we signed that pushed out occupancy, and leases that we signed that have yet to commence, and leases on vacant states that have already commenced that are sort of baked into the numbers. So the numbers that I provided earlier are sort of how we're looking at things on a going forward basis. Instead of the million square feet of leases, for example, that we had that were, or the 1.2, if that was the number you used, of leases that were signed that had yet to commence, right now it's about a million square feet, or 885,000 square feet, of which 700,000 of that are 2023 commencements, and the rest are buildings that will have a lease commencement in 2024, right? So that's sort of how I would sort of look at the numbers. So what I gave you earlier today were the numbers as of, 9-30-2022.

David, I think the only number that Doug gave at the investor conference that was different than what he gave today was he did say at the investor conference the amount of square footage that we had signed for leases that were expiring. Now, those leases are not in our expiration table because we already have signed leases starting for those. I think that number was like 800,000 square feet. So that really doesn't affect the I mean, it affects occupancy, obviously, because it's covered, but we don't have that in our expiration table because the lease is already covered by a signed lease. Just so you kind of understand the methodology of how we use our expiration table. The expiration table only includes space that is expiring where we do not have a new signed lease starting right away.

Thank you.

And I share our next question. It comes from the line of Taya Okunsoya from Credit Suisse. Please go ahead.

Yes. Good morning, everyone. So you guys talked a little bit about, again, the business being a long-term one, which I wholeheartedly agree with. I'm just wondering specifically on the life science side, though. You're clearly creating more exposure. you are taking back space specifically to redevelop into life science. But again, I think, Doug, you also mentioned the comment that life science demand generally seems to be slowing at least near term. So just wondering how you kind of balance those two things, you know, on a going forward basis where demand seems to be slowing, but you're clearly also increasing exposure to that particular industry.

So I'll jump in. Doug may have some comments as well. We have a lot of confidence in the long-term growth prospects in life science. We think there's tremendous capital that is prepared to invest in that space, and there's also tremendous unresearched science, and it has very strong prospects. I think the other thing that's important about life science is the importance of location. It's critically important, and Kendall Center, where we're making most of our investments today is absolutely a key critical, one of the best locations for life science in the world. And I look at all the demand we generated in the deals that we've announced. You know, we talked about the AstraZeneca lease at 290 Binney Street, the Broad lease that we did at 300 Binney. So we're demonstrating very strong demand at that location. So I do think there's been more of a slowdown in Waltham, and therefore we've slowed down a little bit of our new deliveries to be responsive to that. But again, given my prior remarks, we have confidence that that will return.

Yeah, and I would just add that remember that we are looking at our investment decisions over a long term. And it takes a long time to clear a building of existing tenants. And so we want to be in a position where we can start the next building when we're successful leasing the ones that we currently have, or we feel the market has started to dramatically change from a demand perspective. you know, as we enter into the latter parts of 2023, early 2024. So, we're sort of, we're setting ourselves up for these opportunities. And by the way, I mean, I'll just, you know, sort of give you some examples. We actually have three proposals that we're negotiating right now. They're not leases on, you know, a building that's currently vacant in Princeton at Carnegie Center for life science users. And so, you know, having the ability to say to a user, The building is unencumbered, and we can start construction, you know, and if you're interested in signing a lease, we will start construction, is an opportunity that we're trying to create within the portfolio at large. And so, you know, I'd say we're taking some short-term pain for some long-term gain on a going forward basis, but we think it's the right approach to expanding, you know, our ability to do these things, you know, in a thoughtful way. And by the way, and we've said this a number of times, we're not out there buying land for, you know, $200 to $250 in FAR foot, which is what sort of the going price has been for many of these sites, you know, in locations that require rents that are not supported today. We have a very different land basis in our redeveloped assets because of the nature of when the buildings were purchased, when they were built, and, you know, the fact that there is existing infrastructure there that is a value. So we have a a relatively speaking, you know, well-priced portfolio of opportunities that we can bring to the market over time.

Doug, I'd add, this is Brian Coop from Boston Region. I think the prototype is 880 Winter Street for what Doug's talking about. We've got, we're positioning other buildings for the same thing, but as we said at the analyst event, we can turn on and off this faucet of supply with a moment's notice. And we're in a great position on our speculative side with 180 already having pre-leasing on it, good activity, not as strong as it was, but good activity. And then 880 is 100% leased. And we want to have another building just like 880 ready to go when the time is right.

Thank you. And I show our next question comes from the line of Anthony Powell from Barclays. Please go ahead.

Hi, good morning. Question about the March market. I think outside of Boston, which is strong, I think you're seeing basically flat to down 4 or 5% in most of your other geographies. Where do you think that goes the next year or so? And are you seeing any changes in tenant lease terms or length of leases given kind of falling rent here?

So, we're starting to approach the higher rents that we've leased over the past 4 or 5 years in our West Coast markets, and particularly San Francisco, which again is why I, when I provided the statistics for this quarter, I said, you know, we basically were slightly above, it was a couple of percent, and it was about, the average starting rent was over $100 a square foot, right? So we're not seeing declines in rents. We're just not seeing the same relative increases that we were seeing. And so as we get closer to leases that were signed, you know, X number of years ago, there's a tighter, Range associated with with that, that roll up or roll down is relatively speaking the Boston market and the San Francisco market still have the most embedded growth. Our New York City market is very hit or miss. It's summer up and summer down. So, when we leave a piece of space in the mid to high rise of 767, 5th Avenue, the General Motors building will have will have an increase. when we leased a piece of space at 510 Madison Avenue where the rents were done in a decade ago and were increasing significantly and operating expenses went up, we're going to see a decline. So, again, it's very much building by building, lease by lease. And in our Washington, D.C. portfolio, as I described to you, generally those come down you know, in Reston, it's been three to 5%, and in the district, it's been, you know, around 10% because of the nature of the leases from a cash perspective, right? When we actually report gap numbers, we actually won't have these declines because they're, when you, you know, you average a 3% increase for 10 or 15 years on a lease that's starting 10% below what was expiring, you actually have a positive mark to market, but that's not what we're providing. We're providing you with a cash number so you have a perspective on what's going on in the marketplace. So that's sort of my perspective on sort of where the embedded growth is. From a transactional perspective, on the margin, TIs are still very, very elevated. And it depends on what kind of a tenancy you're talking to and what their options are. So the larger requirements where there's more desperation, if you will, from landlords or sub-tenants that have large blocks of available space, there are more aggressive terms. For smaller transactions, you know, a floor or less where the tenant is looking for a premier workspace, we have been able to maintain the economics of the deals that we're doing in our markets, and that includes, you know, San Francisco, which, again, has obviously got a very significant overall, you know, vacancy in it that people report, but where the vacancy in the premier space is still significantly lower.

Thank you. As a reminder, to ask a question, you need to press star 1-1 on your telephone. And I'm sure our next question comes from the line of Anthony Paoloni from J.P. Morgan. Please go ahead.

Thanks. I guess just for Mike, given the discussion and puts and takes on lease commencements next year, where does leverage go over the course of the year? And just remind us where your long-term target is.

So leverage right now is seven and a half times, which is basically in line with where our target is. And, you know, I would expect next year that, you know, it's likely to tick up a little bit before it comes down. And then as our development pipeline delivers later next year and then into the following year, you know, it would start to come down. And then then the dependence is what kind of new investment activity do we have, right? And if we have significant new investment activity, we've got to figure out how to capitalize that. But if we don't have that activity, I think that's kind of the trajectory. So you may still see it increase a little bit and then start to come down.

Thank you. And I share our next question. It comes from the line of Jamie Feldman from Wells Fargo. Please go ahead.

Great. Thank you. I'm here with Blaine. So I guess just sticking with that last response, Mike, your response, thinking about the fact that BXP, clearly the interest rate outlook for the company and impact on earnings has cut the market off guard, probably surprised you guys even where you sit today versus where you thought you'd be a couple of years ago. What does that mean for the competitive landscape? I'm sure there's a bunch of private operators or even public out there that You guys have always run your balance sheet particularly well and more conservative and locked in debt costs better than most. You're starting to see a lot of distress and you expect to see a lot of distress. I know you had mentioned wanting to grow more in residential and life science. Will this open up opportunities and will this stuff be in scale if it's out there? And if so, how would you capitalize it based on where your balance sheet sits today?

Yeah, Jamie, it's Owen. Yes, I think when you go into an environment like this where interest rates have jumped up pretty dramatically fairly quickly, I do think there'll be more distress. I think there'll be less distress in premier workplaces because those assets are going to perform better, and I think lenders and other capital providers will realize that. And, you know, as we move forward, You know, we will continue to look for opportunities. We will be very focused on pricing, you know, given the higher cost of capital that we have. And we will be very focused on our leverage, and I would anticipate, you know, increasing use of joint venture partner equity to manage our balance sheet.

And I think that, look, we've got a lot of cash flow that's coming online from these developments over the next few years. You know, 70% of the debt capital has already been raised that is funding this. So we've got a lot of fallow kind of capital out there on these properties where income hasn't started. So, you know, yes, we expect our leverage to tick up a little bit as we kind of go through the development process over the next few quarters. But if we don't do anything else and we just let this stuff come in, our leverage is going to be down into the, you know, low sixes. And that's below our target range. So there's still capacity on our balance sheet to do things, you know, if we find those opportunities. And then it's a question of how we fund it, right? And I think that in order to continue to lengthen our balance sheet, that's why we've been using private capital to help us fund some of these new opportunities. And I would expect that we would continue to kind of look at that as a vehicle to help us do that Because we're not going to be raising public equity at the kind of prices that we're at right now.

Thank you. And our last question comes from the line of Danielle Ismail from Green Street. Please go ahead.

Great. Thank you. I might be sounding a bit like a broken record here, but I'm just curious, given on our numbers, BXP is trading at some of the widest discounts in history on a variety of metrics, implied cap rates, discounts to NAV. I'm just curious, what would cause any sort of incremental capital to be redirected into share repurchases versus external growth? What are sort of the triggers or is it a a duration of these discounts persisting to see more capital go into, to see capital go into share repurchases, or what would put that back on the table?

I think it's the relative use of capital. So, you know, we might describe we're currently at our target leverage. That might tick up a little bit. Then it comes down over time. We have... I mentioned a couple of additional developments that we're looking at in Kendall Center, which require capital. But I think to look at share repurchases, I think it would be, you know, our leverage is low and we don't have the investment pipeline in front of us that we do right now.

And I think Owen described, right? I mean, we're picky about what we're going to be investing in. The bar has got to be higher, but we have some opportunities. like the ones we've talked about in Kendall Square that are, you know, once-in-a-lifetime kind of opportunities. And these are great transactions that are going to grow the value of this company. So investing our capital in those kinds of opportunities, we believe, will be very creative to our shareholders over time.

Thank you. That concludes our Q&A session. At this time, I'd like to turn the conference back to Owen Thomas, Chairman and CEO, for closing remarks.

Thank you. We have no more formal remarks. Thank you for your interest in BXP.

Thank you. This concludes today's conference call. Thank you for participating. You may now disconnect.

The conference will begin shortly. To raise your hand during Q&A, you can dial star 1 1.